-
Technical Use of EdU Imaging Kits (Cy5) for S-Phase DNA Anal
2026-06-11
EdU Imaging Kits (Cy5) provide a robust alternative to BrdU assays for quantifying cell cycle S-phase DNA synthesis, especially where high sensitivity and minimal sample disruption are essential. These kits streamline fluorescence-based detection without harsh denaturation steps, but are not suitable for applications requiring live-cell tracking or multiplexing beyond the specified fluor channels.
-
Phosphoenolpyruvate Restricts cGAS-STING Inflammation in Agi
2026-06-11
A recent study highlights phosphoenolpyruvate (PEP), a glycolytic metabolite, as an endogenous inhibitor of the cGAS–STING inflammatory pathway, thereby promoting healthy aging by mitigating chronic inflammation. This mechanistic insight reveals new therapeutic directions for age-related diseases and underscores the centrality of metabolic intermediates in regulating inflammation.
-
EdU Imaging Kits (HF594): Practical Guide for DNA Synthesis
2026-06-10
EdU Imaging Kits (HF594) enable direct, sensitive detection of DNA synthesis for cell proliferation assays, overcoming the need for harsh denaturation and antibody staining required by BrdU methods. The kit is ideal for fixed-cell applications using fluorescence microscopy or flow cytometry, but is not suitable for live-cell imaging or for detecting non-S-phase events.
-
Ferrostatin-1 (Fer-1): Reliable Ferroptosis Inhibition in Ce
2026-06-10
This article explores real-world laboratory challenges in ferroptosis research and demonstrates how Ferrostatin-1 (Fer-1, SKU A4371) addresses issues of reproducibility, selectivity, and workflow optimization in cell viability and cytotoxicity assays. Practical Q&A scenarios grounded in recent literature and validated protocols highlight the scientific and operational advantages of selecting APExBIO's Ferrostatin-1 (Fer-1) for advanced biomedical research.
-
Bufalin: Cardiotoic Steroid Transforming Cancer Cell Workflo
2026-06-09
Bufalin, a potent cardiotonic steroid from APExBIO, enables precise apoptosis induction and molecular target degradation in triple-negative breast cancer and hepatocellular carcinoma models. This article delivers actionable workflows, advanced troubleshooting, and protocol enhancements to maximize reproducibility and scientific insight at the bench.
-
Homoharringtonine (SKU N1504): Reliable Solutions for Cytoto
2026-06-09
This article provides practical, scenario-driven guidance for using Homoharringtonine (SKU N1504) in cell viability, proliferation, and SARS-CoV-2 antiviral assays. Drawing on current literature and real laboratory challenges, it explains how this cytotoxic alkaloid ensures reproducibility and sensitivity in advanced cancer and viral research workflows.
-
20-HETE–TRPV1–MrgprA3+ Axis Drives Allokinesis in Chronic De
2026-06-08
This study elucidates how elevated 20-HETE mediates TRPV1 activation on MrgprA3+ sensory neurons, driving itch (allokinesis) in chronic dermatitis. The findings clarify the molecular interface between itch and pain in inflamed skin and highlight new avenues for targeted intervention.
-
MOG (35-55) Peptide: Elevating Autoimmune Encephalomyelitis
2026-06-08
MOG (35-55) Peptide enables precise, reproducible modeling of autoimmune neuroinflammation, empowering advanced multiple sclerosis research. This guide details optimized workflows, troubleshooting strategies, and actionable insights from cutting-edge literature for robust EAE induction and analysis.
-
CSRP2 Regulates PRC1-Mediated PDGFRA/PI3K/AKT in Glioma
2026-06-07
The study uncovers CSRP2 as a mesenchymal glioma-enriched protein that modulates PDGFRA/PI3K/AKT signaling through PRC1 chromatin regulation, impacting tumor growth and aggressiveness. These findings refine the understanding of glioma epigenetics and suggest CSRP2 as a context-dependent biomarker.
-
5X Protein Loading Buffer (Reducing): SDS-PAGE Protocol Guid
2026-06-06
5X Protein Loading Buffer (Reducing) provides consistent denaturation and disulfide bond reduction for SDS-PAGE, enabling accurate protein separation by molecular weight. This buffer is essential in workflows where reducing conditions are required but should not be used for analyses aiming to preserve native or non-reducing protein conformations.
-
PLGA Nano-Adjuvant Boosts Mucosal Immunity in Chick H9N2 Vac
2026-06-05
A recent study developed a double-layered PLGA-based nano-adjuvant encapsulating Lagenaria siceraria polysaccharide and retinoic acid, enhancing both systemic and mucosal immune responses against H9N2 avian influenza in chicks. This approach achieved prolonged intestinal targeting and robust IgA production, suggesting a promising direction for next-generation poultry vaccines.
-
XAV-939: A Precision Tool for Osteogenic and Fibrotic Pathwa
2026-06-05
Discover the unique capabilities of XAV-939 as a potent modulator of Wnt/β-catenin signaling for advanced research in osteogenic differentiation, cancer, and fibrosis. This article reveals new assay strategies and deeper mechanistic insights distinct from existing reviews.
-
Ginsenoside Rg1: Next-Generation Neuroimmune Modulation in R
2026-06-04
Explore how Ginsenoside Rg1, a leading triterpene saponin, enables advanced neuroprotection research through precise immune pathway modulation. This article provides unique protocol insight and rigorous comparative analysis, setting a new benchmark for apoptosis and inflammation studies.
-
Y-27632 ROCK Inhibitor: Optimizing Cytoskeletal Dynamics
2026-06-04
Y-27632 is a benchmark tool for precise modulation of cytoskeletal dynamics in advanced cell models, from stem cell gastruloids to cancer research. This guide distills experimental workflows, troubleshooting strategies, and cutting-edge applications, leveraging insights from large-scale phenotypic screening to maximize reproducibility and biological impact.
-
PPP1R3G/PP1γ Dephosphorylation of RIPK1 Drives Cell Death Pa
2026-06-03
This study uncovers how the regulatory subunit PPP1R3G and its catalytic partner PP1γ facilitate the removal of inhibitory phosphorylations on RIPK1, enabling apoptosis and necroptosis. These findings clarify a critical molecular checkpoint in inflammation and cell death, with implications for targeting the NF-κB pathway in disease models.